Hydroxychloroquine News and Research

RSS
New insight into role of autophagy in controlling SARS-CoV-2 infection

New insight into role of autophagy in controlling SARS-CoV-2 infection

Pharmacophore model helps find key protease inhibitor responsible for COVID-19

Pharmacophore model helps find key protease inhibitor responsible for COVID-19

OHDSI awarded $10 million FDA contract to support Biologics Effectiveness and Safety program

OHDSI awarded $10 million FDA contract to support Biologics Effectiveness and Safety program

Research suggests plant flavonols could serve as effective antivirals for SARS-CoV-2

Research suggests plant flavonols could serve as effective antivirals for SARS-CoV-2

KU Leuven vaccine candidate works against yellow fever and SARS-CoV-2 infection

KU Leuven vaccine candidate works against yellow fever and SARS-CoV-2 infection

Potential SARS-CoV-2 antiviral: Ionophore X-206 found to inhibit viral replication in cell cultures

Potential SARS-CoV-2 antiviral: Ionophore X-206 found to inhibit viral replication in cell cultures

Chloroquine/hydroxychloroquine could treat COVID-19 infection

Chloroquine/hydroxychloroquine could treat COVID-19 infection

Nucleic acid-hydrolyzing scFv 3D8 exhibits potent antiviral effects on SARS-CoV-2

Nucleic acid-hydrolyzing scFv 3D8 exhibits potent antiviral effects on SARS-CoV-2

Rutgers leading a clinical trial assessing combination treatment for coronavirus

Rutgers leading a clinical trial assessing combination treatment for coronavirus

How pharma money colors Operation Warp Speed’s quest to defeat COVID

How pharma money colors Operation Warp Speed’s quest to defeat COVID

Steam inhalation therapy found to inactivate SARS-CoV-2 virions

Steam inhalation therapy found to inactivate SARS-CoV-2 virions

Resveratrol shows potential as SARS-CoV-2 antiviral, study finds

Resveratrol shows potential as SARS-CoV-2 antiviral, study finds

Mefloquine shows potential as anti-SARS-CoV-2 drug

Mefloquine shows potential as anti-SARS-CoV-2 drug

Largest clinical trial launched to treat mild-to-moderate COVID-19 patients in Africa

Largest clinical trial launched to treat mild-to-moderate COVID-19 patients in Africa

Care pathways for pregnant women with COVID‐19

Care pathways for pregnant women with COVID‐19

Drugs targeting neutrophils could reduce ARDS in severe COVID-19

Drugs targeting neutrophils could reduce ARDS in severe COVID-19

Convalescent plasma in COVID-19 can be effective, especially early in disease

Convalescent plasma in COVID-19 can be effective, especially early in disease

Study: Hydroxychloroquine has no effect on abnormal heart rhythm in lupus patients with CKD

Study: Hydroxychloroquine has no effect on abnormal heart rhythm in lupus patients with CKD

Study suggests honey and Nigella sativa expedites viral clearance in COVID-19 patients

Study suggests honey and Nigella sativa expedites viral clearance in COVID-19 patients

Patients with rheumatic diseases reported antimalarial drug shortages during COVID-19

Patients with rheumatic diseases reported antimalarial drug shortages during COVID-19